TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
LTRN

Lantern Pharma Inc

Healthcare · Biotechnology

1.20$ +0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LTRN
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
99.0% 86.1% 99.4% 98.3% 99.8% 99.3% 98.7% 97.9%
99.0% 86.0% 94.4% 69.7% 63.2% 50.3% 29.4% 40.1%
99.0% 86.0% 94.4% 95.6% 93.8% 94.6% 93.9% 91.7%
– – – 0.2% 1.0% 2.0% 0.4% 0.3%
– – – -0.2% -1.0% – – –
1.0% 0.6% 0.1% 0.3% 0.1% – – –
144.9% 34.2% 3.2% 3.2% 4.8% 6.3% 17.1% 40.8%
144.9% 34.2% 2.7% 3.1% 4.8% 6.1% 16.9% 40.8%
– – – 0.2% 0.1% 0.4% 0.7% 711.7%
21.7% 33.4% 2.1% 2.9% 1.6% 2.2% 16.2% 40.1%
– – 0.5% – – – – –
-44.9% 65.8% 96.8% 96.8% 95.2% 93.7% 82.9% 59.2%
-961.1% -471.3% -62.2% -33.8% -66.8% -126.6% -297.3% -844.0%
1,382.2% 437.3% 30.6% 14.7% 18.4% 24.8% 42.1% 98.8%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?